Related Experiment Video
Updated: Jul 7, 2026
07:12
Spatio-Temporal In Vivo Imaging of Ocular Drug Delivery Systems using Fiberoptic Confocal Laser Microendoscopy
Published on: September 27, 2021
[Drug delivery systems for intraocular applications].
J-L Bourges1, E Touchard, L Kowalczuk
1INSERM; CRC, UMRS 872 équipe 17, Physiopathologie des maladies oculaires: innovations thérapeutiques, Paris, France.
Journal Francais D'Ophtalmologie
|February 13, 2008
Summary
Ocular drug delivery systems (DDSs) offer sustained drug release for eye treatments. Advances in design and miniaturization improve efficacy and reduce trauma, with some systems nearing clinical use.
Area of Science:
- Ophthalmology
- Biomaterials Science
- Pharmacology
Context:
- Ocular drug delivery systems (DDSs) are crucial for sustained and calibrated therapeutic release within the eye.
- Significant advancements have been achieved in DDS design, biocompatibility, bioavailability, and efficacy.
- Miniaturization of ocular implants reduces invasiveness and trauma to delicate eye tissues.
Purpose:
- To provide an overview of current and emerging ocular implants for therapeutic applications.
- To highlight the progress in DDS technology for intraocular drug delivery.
- To discuss the potential clinical utility of advanced DDS.
Summary:
- Drug delivery systems (DDSs) are being developed as intraocular tools for controlled drug release.
- Research has focused on improving the design, biocompatibility, bioavailability, and efficacy of these systems.
- Emerging DDSs are becoming less traumatic and offer targeted delivery to specific ocular cells or tissues, with some nearing clinical application.
Impact:
- Ocular implants represent a promising frontier in treating eye diseases with improved drug delivery.
- The development of DDSs facilitates sustained therapeutic effects, potentially enhancing patient outcomes.
- Targeted and less invasive DDSs could revolutionize ophthalmic treatment paradigms.
Related Concept Videos
01:23Ophthalmic Drug Delivery Systems
Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...
01:21Intrauterine Drug Delivery Systems
Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...
01:22Drug Delivery: Miscellaneous Routes
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection, and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs through the...
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs through the...
01:28Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices
Parenteral drug delivery systems play a crucial role in modern therapeutics by enabling the direct administration of drugs into the systemic circulation, bypassing the gastrointestinal tract. These systems are particularly valuable for poorly absorbed oral medications that are unstable in the digestive environment or require rapid onset or sustained therapeutic levels. Delivery is achieved through intravenous, intramuscular, or subcutaneous routes, each selected based on the drug's properties...
01:24Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
01:27Drug Delivery Systems: Different Types
Conventional oral drug products, termed immediate-release (IR) formulations, are engineered to promptly release their active pharmaceutical ingredient (API) upon ingestion, typically in tablets or capsules. This rapid release often results in swift drug absorption and consequent pharmacodynamic effects, although the timing and intensity can vary depending on the drug's properties. Prodrugs within these formulations require metabolic conversion to activate their pharmacodynamic effects,...